Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effects of Cardiac Contractility Modulation (CCM) With the OPTIMIZER III System in Subjects With Heart Failure Caused by Left Ventricular Dysfunction

NCT02895048 is registered in ClinicalTrials.gov with Stiftung Institut fuer Herzinfarktforschung as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02895048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effects of Cardiac Contractility Modulation (CCM) With the OPTIMIZER III System in Subjects With Heart Failure Caused by Left Ventricular Dysfunction
Lead sponsor
Stiftung Institut fuer Herzinfarktforschung
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
November 30, 2013
Enrollment
184 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.